https://wiki.tradeville.ro/index.php?action=history&feed=atom&title=COHERUS_BIOSCIENCES_INCCOHERUS BIOSCIENCES INC - Revizia istoricului2026-05-15T19:47:55ZIstoricul versiunilor pentru această pagină din wikiMediaWiki 1.39.2https://wiki.tradeville.ro/index.php?title=COHERUS_BIOSCIENCES_INC&diff=412471&oldid=prevAdmin: Pagină nouă: Pagina dedicata companiei COHERUS BIOSCIENCES INC listata cu simbolul US.CHRS ==Descriere companie== Coherus BioSciences, Inc. (www.coherus.com) is a commercial stage biotherapeutics company. The Company is focused on the biosimilar and immuno-oncology market primarily in the United States. The Company’s pipeline includes the four categories product candidates, Oncology pipeline, Immunology pipeline, Ophthalmology pipeline and Small Molecule pipeline. Oncology pipeline inc...2024-09-18T13:47:03Z<p>Pagină nouă: Pagina dedicata companiei COHERUS BIOSCIENCES INC listata cu simbolul US.CHRS ==Descriere companie== Coherus BioSciences, Inc. (www.coherus.com) is a commercial stage biotherapeutics company. The Company is focused on the biosimilar and immuno-oncology market primarily in the United States. The Company’s pipeline includes the four categories product candidates, Oncology pipeline, Immunology pipeline, Ophthalmology pipeline and Small Molecule pipeline. Oncology pipeline inc...</p>
<p><b>Pagină nouă</b></p><div>Pagina dedicata companiei COHERUS BIOSCIENCES INC listata cu simbolul US.CHRS<br />
<br />
==Descriere companie==<br />
Coherus BioSciences, Inc. (www.coherus.com) is a commercial stage biotherapeutics company. The Company is focused on the biosimilar and immuno-oncology market primarily in the United States. The Company’s pipeline includes the four categories product candidates, Oncology pipeline, Immunology pipeline, Ophthalmology pipeline and Small Molecule pipeline. Oncology pipeline includes Toripalimab, an anti-PD-1 antibody; UDENYCA (pegfilgrastim-cbqv); CHS-305, a bevacizumab (Avastin) biosimilar. Immunology pipeline includes CHS-1420, an anti-TNF product candidate, as an adalimumab (Humira) biosimilar. Ophthalmology pipeline includes CHS-201, a ranibizumab (Lucentis) biosimilar. CHS-201, a ranibizumab (Lucentis) biosimilar. Small Molecule pipeline includes CHS-131, an oral, small-molecule drug candidate. CHS-131 is a once-daily oral drug candidate for non-alcoholic steatohepatitis (NASH) and other metabolic conditions.<br />
<br />
==Grafic actiuni companie==<br />
<iframe key="tradeville" path="graficSimbol/US.CHRS" /><br />
<br />
==Ultimele stiri despre COHERUS BIOSCIENCES INC (US.CHRS)==<br />
<dynamicpagelist><br />
category=US.CHRS<br />
count=10<br />
order=descending<br />
addfirstcategorydate=false<br />
</dynamicpagelist><br />
<br />
[[Categorie:US.CHRS]][[Categorie:Stiri despre companii]]</div>Admin